Latest News in the pharma Industry
Top Stories
Pfizer–Allergan merger agreement terminated
6 Apr 2016
Allergan reiterates strong standalone growth profile and strategy following termination of Pfizer transaction.
Read more
Engineers develop a pill for long-term drug release
6 Apr 2016
New tablet attaches to the lining of the GI tract, resists being pulled away.
Read more
Sir Andrew Witty to retire from GSK in March 2017
17 Mar 2016
The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role.
Read more
CMA fines pharma companies £45 million
12 Feb 2016
The CMA has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine.
Read more
Shire to combine with Baxalta, creating the global leader in rare diseases
11 Jan 2016
Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.
Read more
UBM celebrates securing more than 36000 attendees at biggest ever CPhI Worldwide
7 Jan 2016
World’s largest pharma event sees record exhibitor numbers in Madrid.
Read more
Pfizer and Allergan to combine
23 Nov 2015
As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of...
Read more
BMS to sell its HIV R&D portfolio to ViiV Healthcare
18 Dec 2015
Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June.
Read more
Catalent working to re-start production at French facility
16 Nov 2015
Company’s preliminary investigation indicates tha the incidents of out-of-place softgel capsules in several product batches could be related to a deliberate action by one or more individuals.
Read more
Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy
13 Nov 2015
Perrigo will immediately commence its previously announced $2 billion repurchase of Perrigo shares and plans to complete $500 million of the planned repurchase by the end of 2015.
Read more
Roche to restructure its manufacturing network for small molecules
13 Nov 2015
Exiting four sites to optimise capacity utilisation will affect approximately 1,200 positions.
Read more
Sanofi Pasteur reveals its research on a ”universal” influenza vaccine
9 Nov 2015
The vaccines division of Sanofi presents at the World Vaccine Congress in Spain.
Read more